Novartis, Tory Burch, Ashley Madison: Intellectual Property

Updated on

(Bloomberg) -- Novartis AG’s Sandoz unit may begin selling the first copy of Amgen Inc.’s cancer treatment Neupogen as soon as Sept. 2 after an appeals court ruling Tuesday rejected arguments that it failed to follow regulatory rules.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.